Based on the argenx SE stock forecast from 0 analysts, the average analyst target price for argenx SE is not available over the next 12 months. argenx SE’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of argenx SE is Slightly Bullish , which is based on 5 positive signals and 4 negative signals. At the last closing, argenx SE’s stock price was USD 697.42. argenx SE’s stock price has changed by +0.00% over the past week, +11.53% over the past month and +78.02% over the last year.
No recent analyst target price found for argenx SE
No recent average analyst rating found for argenx SE
argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myastheni...Read More
Frequently Asked Questions About argenx SE (ARGNF) Stock
Stock Target Advisor's fundamental analysis for argenx SE's stock is Slightly Bullish .
Unfortunately we do not have enough data on ARGNF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ARGNF's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ARGNF's stock to indicate if its overvalued.
The last closing price of ARGNF's stock was USD 697.42.
The most recent market capitalization for ARGNF is USD 42.38B.
Unfortunately we do not have enough analyst data on ARGNF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains argenx SE's stock.
As per our most recent records argenx SE has 1,148 Employees.
argenx SE's registered address is Laarderhoogtweg 25, Amsterdam, Netherlands, 1101EB.
You can get more information about it from argenx SE's website at https://www.argenx.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About argenx SE (ARGNF) Stock
Stock Target Advisor's fundamental analysis for argenx SE's stock is Slightly Bullish .
Unfortunately we do not have enough data on ARGNF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ARGNF's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ARGNF's stock to indicate if its overvalued.
The last closing price of ARGNF's stock was USD 697.42.
The most recent market capitalization for ARGNF is USD 42.38B.
Unfortunately we do not have enough analyst data on ARGNF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains argenx SE's stock.
As per our most recent records argenx SE has 1,148 Employees.
argenx SE's registered address is Laarderhoogtweg 25, Amsterdam, Netherlands, 1101EB.
You can get more information about it from argenx SE's website at https://www.argenx.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ARGNF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
